Terug
Dagbereik
€ 75,71
€ 81,29
52-Weeksbereik
€ 19,45
€ 103,00
Volume
923.929
50D / 200D Gem.
€ 79,67
/
€ 61,62
Vorige Slotkoers
€ 74,42
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -20,7 | 0,2 |
| P/B | 4,1 | 3,0 |
| ROE % | -25,8 | 3,6 |
| Net Margin % | -794,4 | 3,8 |
| Rev Growth 5Y % | -14,4 | 9,9 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 117,31
+48.6%
Low: € 90,00
High: € 138,00
Forward WPA
-€ 3,66
Omzet Sch.
39,61M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 3,41
-€ 9,67 – € 0,66
|
222,18M | 12 |
| FY2029 |
-€ 4,31
-€ 12,21 – € 0,84
|
54,14M | 8 |
| FY2028 |
-€ 4,10
-€ 4,99 – -€ 3,09
|
43,17M | 14 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | -€ 0,78 | -€ 0,97 | -23,8% |
| 2025-11-04 | -€ 0,71 | -€ 0,90 | -26,8% |
| 2025-08-11 | -€ 0,83 | -€ 0,95 | -14,5% |
| 2025-05-09 | -€ 0,92 | -€ 0,82 | +10,9% |
| 2025-02-27 | -€ 0,76 | -€ 0,88 | -15,8% |
| 2024-10-31 | -€ 0,83 | -€ 0,82 | +1,2% |
| 2024-08-07 | -€ 0,69 | -€ 0,58 | +15,9% |
| 2024-05-02 | -€ 0,73 | -€ 0,69 | +5,5% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue declined -14,35% annually over 5 years
Debt/Equity of 0,05 — conservative balance sheet
Negative free cash flow of -234,34M
Capital efficient — spends only 3,70% of revenue on capex
Groei
Revenue Growth (5Y)
-14,35%
Revenue (1Y)-16,72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-25,79%
ROIC-15,77%
Net Margin-794,39%
Op. Margin-891,33%
Veiligheid
Debt / Equity
0,05
Current Ratio10,47
Interest Coverage-1403,21
Waardering
P/E Ratio
-20,69
Forward P/EN/A
P/B Ratio4,08
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -16,72% | Revenue Growth (3Y) | -29,38% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -14,35% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 39,20M | Net Income (TTM) | -311,40M |
| ROE | -25,79% | ROA | -17,87% |
| Gross Margin | 100,00% | Operating Margin | -891,33% |
| Net Margin | -794,39% | Free Cash Flow (TTM) | -234,34M |
| ROIC | -15,77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,05 | Current Ratio | 10,47 |
| Interest Coverage | -1403,21 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -20,69 | Forward P/E | N/A |
| P/B Ratio | 4,08 | P/S Ratio | 164,39 |
| PEG Ratio | -0,89 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 162,68 | Fwd Earnings Yield | N/A |
| FCF Yield | -3,64% | ||
| Market Cap | 6,44B | Enterprise Value | 6,17B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 39,20M | 47,07M | 78,59M | 46,83M | 72,83M |
| Net Income | -311,40M | -223,86M | -146,96M | -154,81M | -100,22M |
| EPS (Diluted) | -3,69 | -2,98 | -2,52 | -2,87 | -2,09 |
| Gross Profit | 39,20M | 47,07M | 78,59M | 46,83M | 72,83M |
| Operating Income | -349,40M | -261,64M | -165,53M | -161,26M | -100,53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,74B | 978,04M | 575,76M | 603,13M | 605,91M |
| Total Liabilities | 163,15M | 142,42M | 180,79M | 112,98M | 146,27M |
| Shareholders' Equity | 1,58B | 835,62M | 394,97M | 490,15M | 459,64M |
| Total Debt | 82,25M | 87,76M | 84,67M | 17,34M | 17,96M |
| Cash & Equivalents | 357,01M | 120,26M | 109,97M | 68,40M | 47,98M |
| Current Assets | 871,21M | 510,27M | 405,32M | 419,42M | 451,27M |
| Current Liabilities | 83,21M | 67,77M | 85,69M | 71,34M | 92,54M |